Mutat Res. 2026 Nov 04. pii: S1386-1964(26)00027-8. [Epub ahead of print]833
111954
BACKGROUND: Lung adenocarcinoma (LUAD), the predominant subtype of lung cancer, has limited therapeutic options. Dysregulation of the NF‑κB pathway and M2‑type polarization of macrophages (Macs) drive LUAD progression. GPR87, a member of the GPCR family, is overexpressed in multiple malignancies, including lung cancer, and has been demonstrated to activate NF-κB in pancreatic cancer. However, the function of GPR87 in LUAD and its role in microenvironment remodeling remain unclear.
METHODS: GPR87 levels in LUAD were analyzed by utilizing the TCGA database. The Kaplan-Meier was utilized for prognostic evaluation. The qPCR and WB were used to assess GPR87 levels in LUAD cell lines. A549 cell GPR87 overexpression model and NCI-H1975 cell GPR87 knockdown model were constructed, and through colony formation, CCK-8, flow cytometry and ELISA, the effects of GPR87 on cell progression, NF-κB signaling pathway and cytokine secretion were explored. A co-cultivation system of A549 cells and THP-1-derived Macs was employed to validate the regulatory effect of the GPR87/NF-κB axis on M2 polarization of Macs via flow cytometry, morphological observation, and ELISA, and validation was also performed using primary Macs derived from PBMCs. In addition, an syngeneic tumor model was established by utilizing C57BL/6 mice, and tumor proliferation, apoptosis, and protein expression were assessed through IHC and TUNEL staining.
RESULTS: TCGA-LUAD analysis showed that GPR87 was significantly upregulated in LUAD tissues, and GEPIA2 Kaplan-Meier analysis indicated that its high expression was associated with poor overall survival. qPCR and WB further validated the upregulation of GPR87 in LUAD cell lines. In A549 cells, overexpression of GPR87 enhanced colony formation ability and inhibited apoptosis, accompanied by activation of the NF-κB pathway, whereas knockdown of GPR87 produced opposite phenotypic effects. Mechanistic studies showed that the GPR87/NF-κB signaling axis induced THP-1-derived Macs to polarize toward the M2 phenotype, and this result was validated in primary Macs derived from PBMCs. In vivo experiments showed that GPR87 overexpression enhanced the tumorigenic ability of LLC cells, whereas this effect was significantly attenuated by the NF-κB inhibitor BAY 11-7082.
CONCLUSIONS: GPR87 promotes the malignant phenotype of LUAD cells and induces M2 polarization of Macs via activating the NF-κB signaling pathway. GPR87/NF-κB axis may serve as a novel therapeutic target for LUAD.
Keywords: GPR87; Lung adenocarcinoma; M2 polarization of macrophages; NF-κB pathway